Peter Brex

2.0k total citations · 1 hit paper
27 papers, 1.4k citations indexed

About

Peter Brex is a scholar working on Pathology and Forensic Medicine, Neurology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Peter Brex has authored 27 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pathology and Forensic Medicine, 9 papers in Neurology and 6 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Peter Brex's work include Multiple Sclerosis Research Studies (16 papers), Peripheral Neuropathies and Disorders (9 papers) and Pregnancy and Medication Impact (5 papers). Peter Brex is often cited by papers focused on Multiple Sclerosis Research Studies (16 papers), Peripheral Neuropathies and Disorders (9 papers) and Pregnancy and Medication Impact (5 papers). Peter Brex collaborates with scholars based in United Kingdom, United States and Italy. Peter Brex's co-authors include Alan J. Thompson, David H. Miller, Olga Ciccarelli, J O’Riordan, Michael Sailer, David MacManus, Katherine Miszkiel, Ruth Dobson, Catherine M. Dalton and Gordon T. Plant and has published in prestigious journals such as New England Journal of Medicine, Annals of Neurology and Journal of Neurology Neurosurgery & Psychiatry.

In The Last Decade

Peter Brex

23 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Longitudinal Study of Abnormalities on MRI and Disability from Multiple Sclerosis

2002 631 citations Peter Brex, Olga Ciccarelli et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Peter Brex United Kingdom	14	1.1k	550	349	205	150	27	1.4k
Wallace Brownlee United Kingdom	20	1.1k 1.0×	503 0.9×	232 0.7×	144 0.7×	212 1.4×	66	1.5k
DH Miller United Kingdom	14	939 0.8×	445 0.8×	322 0.9×	198 1.0×	109 0.7×	16	1.4k
C.H. Polman Netherlands	13	1.2k 1.0×	527 1.0×	318 0.9×	202 1.0×	134 0.9×	22	1.4k
Channa Kolb United States	21	807 0.7×	301 0.5×	199 0.6×	159 0.8×	144 1.0×	50	1.2k
P. Perini Italy	24	1.5k 1.3×	636 1.2×	470 1.3×	278 1.4×	273 1.8×	55	1.9k
Siobhan M Leary United Kingdom	18	1.4k 1.2×	566 1.0×	464 1.3×	336 1.6×	172 1.1×	32	1.7k
Aaron Boster United States	22	925 0.8×	405 0.7×	207 0.6×	168 0.8×	239 1.6×	44	1.4k
Dina Jacobs United States	21	970 0.8×	625 1.1×	408 1.2×	159 0.8×	87 0.6×	48	2.2k
Emma Tallantyre United Kingdom	21	1.4k 1.2×	691 1.3×	327 0.9×	372 1.8×	305 2.0×	72	2.0k
Kryshani Fernando United Kingdom	14	967 0.8×	434 0.8×	320 0.9×	236 1.2×	167 1.1×	18	1.2k

Countries citing papers authored by Peter Brex

Since Specialization

Citations

This map shows the geographic impact of Peter Brex's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Brex with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Brex more than expected).

Fields of papers citing papers by Peter Brex

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Brex. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Brex. The network helps show where Peter Brex may publish in the future.

Co-authorship network of co-authors of Peter Brex

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Brex. A scholar is included among the top collaborators of Peter Brex based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Brex. Peter Brex is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bechman, Katie, Mark Russell, Mark Gibson, et al.. (2025). Incidence, prevalence, and mortality of sarcoidosis in England: a population-based study. The Lancet Regional Health - Europe. 53. 101283–101283. 1 indexed citations

Wood, David M., et al.. (2025). Clinicians’ perspectives on the use of artificial intelligence to triage MRI brain scans. European Journal of Radiology. 183. 111921–111921. 1 indexed citations

Brex, Peter, Bo Chen, Sarah Cooper, et al.. (2024). Study of seasonality of attacks in MOG antibody-associated disease. Multiple Sclerosis and Related Disorders. 90. 105814–105814. 1 indexed citations

Wiles, Kate, Azza Ismail, Surabhi Nanda, et al.. (2023). Developing evidence-based guidelines for the safety of symptomatic drugs in multiple sclerosis during pregnancy and breastfeeding: A systematic review and Delphi consensus. Multiple Sclerosis Journal. 29(3). 395–406. 1 indexed citations

Jaffer, Fatima, et al.. (2022). A case of encephalopathy following a 10k run. Journal of Neurology Neurosurgery & Psychiatry. 93(6). A100.1–A100.

Dobson, Ruth, David Rog, Caroline Ovadia, et al.. (2022). Anti-CD20 therapies in pregnancy and breast feeding: a review and ABN guidelines. Practical Neurology. 23(1). 6–14. 24 indexed citations

Rog, David, Helen Ford, Katy Murray, et al.. (2021). UK variance in DMT advice and prescribing in MS and pregnancy: Impact of the UK consensus on pregnancy in multiple sclerosis ABN guidelines. Multiple Sclerosis and Related Disorders. 56. 103272–103272. 4 indexed citations

Carotenuto, Antonio, Heather Wilson, Beniamino Giordano, et al.. (2020). Impaired connectivity within neuromodulatory networks in multiple sclerosis and clinical implications. Journal of Neurology. 267(7). 2042–2053. 25 indexed citations

Dobson, Ruth, et al.. (2019). UK consensus on pregnancy in multiple sclerosis: ‘Association of British Neurologists’ guidelines. Practical Neurology. 19(2). 106–114. 120 indexed citations

10.

Rabinowich, Liane, et al.. (2019). PTU-031 Drug induced liver injury among patients with multiple sclerosis treated with alemtuzumab- a single-centre experience. A127.2–A127.

11.

Altmann, Daniel R., Frederik Barkhof, Katherine Miszkiel, et al.. (2019). A 30‐Year Clinical and Magnetic Resonance Imaging Observational Study of Multiple Sclerosis and Clinically Isolated Syndromes. Annals of Neurology. 87(1). 63–74. 68 indexed citations

12.

Carotenuto, Antonio, Beniamino Giordano, George Dervenoulas, et al.. (2019). [18F]Florbetapir PET/MR imaging to assess demyelination in multiple sclerosis. European Journal of Nuclear Medicine and Molecular Imaging. 47(2). 366–378. 20 indexed citations

13.

Absoud, Michael, Peter Brex, Olga Ciccarelli, et al.. (2017). A multicentre randomiSed controlled TRial of IntraVEnous immunoglobulin compared with standard therapy for the treatment of transverse myelitis in adults and children (STRIVE). Health Technology Assessment. 21(31). 1–50. 16 indexed citations

14.

Silber, Eli, et al.. (2017). The spectrum of psychosis in multiple sclerosis: a clinical case series. Neuropsychiatric Disease and Treatment. Volume 13. 303–318. 13 indexed citations

15.

Kolind, Shannon, Anna Combes, Roger Tam, et al.. (2015). Brain and cord myelin water imaging: a progressive multiple sclerosis biomarker. NeuroImage Clinical. 9. 574–580. 41 indexed citations

16.

Dalton, Catherine M., Peter Brex, Katherine Miszkiel, et al.. (2003). New T2 lesions enable an earlier diagnosis of multiple sclerosis in clinically isolated syndromes. Annals of Neurology. 53(5). 673–676. 54 indexed citations

17.

Dalton, Catherine M., Peter Brex, Katherine Miszkiel, et al.. (2002). Application of the new McDonald criteria to patients with clinically isolated syndromes suggestive of multiple sclerosis. Annals of Neurology. 52(1). 47–53. 207 indexed citations

18.

Ciccarelli, Olga, Peter Brex, Alan J. Thompson, & David H. Miller. (2002). Disability and lesion load in MS: a reassessment with MS functional composite score and 3D fast FLAIR. Journal of Neurology. 249(1). 18–24. 38 indexed citations

19.

Brex, Peter, Olga Ciccarelli, J O’Riordan, et al.. (2002). A Longitudinal Study of Abnormalities on MRI and Disability from Multiple Sclerosis. New England Journal of Medicine. 346(3). 158–164. 631 indexed citations breakdown →

20.

Leary, Siobhan M, Peter Brex, David MacManus, et al.. (2000). A 1H magnetic resonance spectroscopy study of aging in parietal white matter: implications for trials in multiple sclerosis. Magnetic Resonance Imaging. 18(4). 455–459. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact